Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

World journal of urology·2024
Same author

Initial Experience of Robot Assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction Using the Hinotori Surgical Robot System.

The international journal of medical robotics + computer assisted surgery : MRCAS·2024
Same author

Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53.

The Prostate·2024
Same author

Temporal declines in bone mineral density and trabecular bone score during androgen deprivation therapy.

Journal of bone and mineral metabolism·2024
Same author

Predictive factors for prolonged operative time in ureteroscopic lithotripsy for ureteral stones A retrospective cohort study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2024
Same author

Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors.

Molecular and clinical oncology·2024

Related Experiment Video

Updated: May 30, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

[Tuberculosis in urogenital organs].

Hideaki Miyake1, Masato Fujisawa

  • 1Division of Urology, Kobe University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 16, 2011
PubMed
Summary

Genitourinary tuberculosis is rare but still requires informed diagnosis and treatment, especially in Japan. Intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer can cause infectious adverse events.

Area of Science:

  • Urology
  • Infectious Diseases
  • Oncology

Context:

  • Genitourinary tuberculosis diagnosis is decreasing globally due to chemotherapy advancements.
  • Tuberculosis incidence remains high in Japan, particularly among the elderly.
  • Intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer frequently causes infectious adverse events.

Purpose:

  • To summarize key aspects of genitourinary tuberculosis diagnosis and treatment.
  • To review BCG infection following intravesical instillation therapy for bladder cancer.

Summary:

  • This review addresses the ongoing necessity of understanding genitourinary tuberculosis.
  • It highlights the challenges posed by BCG therapy complications in bladder cancer patients.
  • The content focuses on essential information for clinicians managing these conditions.

Related Experiment Videos

Last Updated: May 30, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Impact:

  • Enhances awareness of genitourinary tuberculosis in specific populations and clinical settings.
  • Provides critical insights into managing adverse events from BCG therapy.
  • Aims to improve patient outcomes through informed diagnosis and treatment strategies.